Back to search

Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging

Data up to Jan 2025

Published2006
Citations264
References57

Total Citations Per Year

Abstract

References (57)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2005 • 7,244 citations

Cost-Effectiveness in Health and Medicine

1996 • 6,853 citations

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2003 • 3,497 citations

The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews

1997 • 2,255 citations

Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

2003 • 2,170 citations

Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening

2005 • 1,800 citations

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

2004 • 1,687 citations

Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations

2002 • 1,650 citations

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1995 • 1,602 citations

Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations

2002 • 1,448 citations

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

2003 • 1,286 citations

Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

2004 • 1,170 citations

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

2004 • 1,103 citations

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

2005 • 1,020 citations

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

2001 • 945 citations

The Beaver Dam Health Outcomes study

1993 • 748 citations

Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

2004 • 611 citations

Breast MR Imaging Screening in 192 Women Proved or Suspected to Be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results

2000 • 549 citations

Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer

2000 • 537 citations

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

2000 • 536 citations

Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening

2006 • 500 citations

Improved survival in women with BRCA‐associated ovarian carcinoma

2003 • 430 citations

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1996 • 427 citations

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging

2005 • 394 citations

Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13

1997 • 389 citations

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

2000 • 266 citations

Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age

1997 • 258 citations

Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer

2006 • 237 citations

First experiences in screening women at high risk for breast cancer with MR imaging

2000 • 220 citations

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

2002 • 204 citations

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography

2002 • 198 citations

High grade and non-high grade ductal carcinomain situon dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement

2003 • 157 citations

Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis

2002 • 152 citations

The development of interval breast malignancies in patients with BRCA mutations

2004 • 151 citations

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer

2000 • 148 citations

Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis

2003 • 147 citations

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.

2002 • 143 citations

Appropriateness of breast‐conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2

2004 • 127 citations

Utilization of Screening and Preventive Surgery Among Unaffected Carriers of aBRCA1orBRCA2Gene Mutation

2004 • 113 citations

Cost Comparison of Mastectomy Versus Breast-Conserving Therapy for Early-Stage Breast Cancer

2001 • 112 citations

Decision Analysis of Prophylactic Surgery or Screening for BRCA1 Mutation Carriers: A More Prominent Role For Oophorectomy

2002 • 90 citations

Cost of Illness Associated with Metastatic Breast Cancer

2004 • 83 citations

A natural history model of stage progression applied to breast cancer

2006 • 69 citations

The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.

1999 • 62 citations

Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer

1999 • 61 citations

Chapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000

2006 • 47 citations

Economic outcomes of breast cancer survivorship: CALGB study 79804

2005 • 43 citations

Trends in Recall, Biopsy, and Positive Biopsy Rates for Screening Mammography in an Academic Practice

2005 • 43 citations

The economic burden of gynecologic cancers in California, 1998

2003 • 39 citations

Initial Experience with Surgical Treatment Planning in the Newly Diagnosed Breast Cancer Patient at High Risk for BRCA-1 or BRCA-2 Mutation

2004 • 33 citations

Breast Cancer and Fatigue

1998 • 31 citations

Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction

2000 • 30 citations

Is adjuvant therapy for older patients with node (−) early breast cancer cost-effective?

2004 • 27 citations

Tamoxifen As Chemoprevention in BRCA1 and BRCA2 Mutation Carriers With Breast Cancer: A Pilot Survey of Physicians

2003 • 26 citations

Breast MRI Screening in Patients with Increased Familial and/or Genetic Risk for Breast Cancer: A Preliminary Experience

2003 • 18 citations

Ethical Issues in Contrast-Enhanced Magnetic Resonance Imaging Screening for Breast Cancer

2002 • 10 citations

Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer

2003 • 5 citations

Cited By (0)

No citing papers found in database

Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance… (2006) – JAMA | Metascience Observatory Explorer